Dr. Lecia Sequist talks about Early Detection with Billy Costa
Mass General Cancer Center's Dr. Lecia Sequist sits down with Kiss 108's Billy Costa to discuss the importance of early detection.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Contact Information
Boston, MAPhone: 617-724-4000
Newton, MAPhone: 617-219-1230
Dr. Sequist is originally from Michigan and studied chemistry at Cornell University. She received her MD from Harvard Medical School and trained in internal medicine at the Brigham and Women’s Hospital and in hematology/oncology at the Dana-Farber Cancer Institute, where she also received an MPH from the Harvard School of Public Health. She joined the faculty at the Massachusetts General Hospital Cancer Center in 2005 and has an active clinical and translational research career, as well as a busy practice caring for patients with lung cancer. She is currently the Landry Family Professor of Medicine at Harvard Medical School and the Director of the Center for Innovation in Early Cancer Detection at Massachusetts General Hospital. She has held grants from the NIH, the DOD, and many private foundations. Dr. Sequist’s research focuses on studying targeted therapeutics for lung cancer and bringing new non-invasive tests like circulating tumor cells and circulating tumor DNA to treat and detect lung cancer. In her free time, she likes to spend time with her husband, two sons and her dog, and is a hockey and dance mom.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Center for Thoracic Cancers, MGH Cancer Center
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Fax: 617-726-0453
MGH Cancer Center at Newton-Wellesley Hospital
2014 Washington St
Newton, MA 02462
Phone: 617-219-1230
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
Mass General Cancer Center's Dr. Lecia Sequist sits down with Kiss 108's Billy Costa to discuss the importance of early detection.
Clinical trials conducted by researchers at the Massachusetts General Cancer Center show encouraging results for the third generation EGFR inhibitor in treating NSCLC with reduced side effects.
The Mass General Cancer Center's Dr. David Ryan and Dr. Lecia Sequist were named leaders for two of the four teams.